Jason T Rodier1,2, Ratnakar Tripathi1,3, Michael K Fink1,3, Ajay Sharma1,3, Madhuri Korampally1,4, Shubhra Gangopadhyay4, Elizabeth A Giuliano1,3, Prashant R Sinha1,3, Rajiv R Mohan1,2,3. 1. 1 Research Divison, Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri. 2. 2 Mason Eye Institute, School of Medicine & Vision, University of Missouri, Columbia, Missouri. 3. 3 One-Health One-Medicine Ophthalmology Research Center, University of Missouri, Columbia, Missouri. 4. 4 Department of Electrical and Computer Engineering, University of Missouri, Columbia, Missouri.
Abstract
PURPOSE: This study investigated the efficiency and potential toxicity of a linear 22-kDa polyethylenimine (PEI)-DNA nanoconstruct for delivering genes to corneal cells and the effects of PEI nitrogen-to-DNA phosphate (N:P) ratio on gene transfer efficiency in vitro and in vivo. METHODS: A gel retardation assay, zeta potential measurement, bright-field microscopy, transfection with green fluorescent protein (GFP), immunofluorescence, and enzyme-linked immunosorbent assay (ELISA) were used to characterize the physicochemical and biological properties and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase (LDH), and reactive oxygen species (ROS) assay for cytotoxicity of the linear PEI-DNA nanoconstruct using in vitro cultured primary human corneal fibroblast and in vivo mouse models. RESULTS: Of the several evaluated N:P ratios, the highest gene transfection efficiency achieved without any notable cytotoxicity was observed at an N:P ratio of 30:1 (N:P 30). In vivo gene transfer studies revealed substantial GFP gene delivery into the corneas of mice 3 days after a single 5-min topical application without any significant adverse ocular effects. Slit-lamp biomicroscope ophthalmic examination of the mouse exposed to the linear PEI-DNA nanoconstruct showed no evidence of hyperemia (redness), corneal edema, ocular inflammation, or epiphora (excessive tearing). CONCLUSIONS: The 22-kDa linear PEI-DNA nanoconstruct is an efficient and well-tolerated vector for corneal gene therapy in vitro and in vivo and could be used as a platform for developing novel gene-based nanomedicine approaches for corneal diseases.
PURPOSE: This study investigated the efficiency and potential toxicity of a linear 22-kDa polyethylenimine (PEI)-DNA nanoconstruct for delivering genes to corneal cells and the effects of PEInitrogen-to-DNA phosphate (N:P) ratio on gene transfer efficiency in vitro and in vivo. METHODS: A gel retardation assay, zeta potential measurement, bright-field microscopy, transfection with green fluorescent protein (GFP), immunofluorescence, and enzyme-linked immunosorbent assay (ELISA) were used to characterize the physicochemical and biological properties and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase (LDH), and reactive oxygen species (ROS) assay for cytotoxicity of the linear PEI-DNA nanoconstruct using in vitro cultured primary humancorneal fibroblast and in vivo mouse models. RESULTS: Of the several evaluated N:P ratios, the highest gene transfection efficiency achieved without any notable cytotoxicity was observed at an N:P ratio of 30:1 (N:P 30). In vivo gene transfer studies revealed substantial GFP gene delivery into the corneas of mice 3 days after a single 5-min topical application without any significant adverse ocular effects. Slit-lamp biomicroscope ophthalmic examination of the mouse exposed to the linear PEI-DNA nanoconstruct showed no evidence of hyperemia (redness), corneal edema, ocular inflammation, or epiphora (excessive tearing). CONCLUSIONS: The 22-kDa linear PEI-DNA nanoconstruct is an efficient and well-tolerated vector for corneal gene therapy in vitro and in vivo and could be used as a platform for developing novel gene-based nanomedicine approaches for corneal diseases.
Entities:
Keywords:
N:P ratio; cornea; fibroblast; gene delivery; linear PEI nanoparticles
Authors: Andrei A Kramerov; Ruchi Shah; Hui Ding; Eggehard Holler; Sue Turjman; Yaron S Rabinowitz; Sean Ghiam; Ezra Maguen; Clive N Svendsen; Mehrnoosh Saghizadeh; Julia Y Ljubimova; Alexander V Ljubimov Journal: Nanomedicine Date: 2020-11-10 Impact factor: 5.307
Authors: Suneel Gupta; Sabeeh Kamil; Prashant R Sinha; Jason T Rodier; Shyam S Chaurasia; Rajiv R Mohan Journal: Toxicol Lett Date: 2021-01-06 Impact factor: 4.271
Authors: Dun Jack Fu; Edwin H A Allen; Robyn P Hickerson; Deena M Leslie Pedrioli; W H Irwin McLean Journal: Transl Vis Sci Technol Date: 2020-12-29 Impact factor: 3.283
Authors: Praveen K Balne; Nishant R Sinha; Alexandria C Hofmann; Lynn M Martin; Rajiv R Mohan Journal: Ann N Y Acad Sci Date: 2020-09-20 Impact factor: 6.499